Illumina Q4 Revenues Jump 25 Percent; Forecasts 15 to 17 Percent Growth in 2014 | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina reported after the close of the market on Tuesday that revenues in its fourth quarter increased 25 percent year over year, including a 21 percent bump in product revenues.

The San Diego-based company said that for the last three months of 2013, it took in $387.3 million in total revenues, up from $309.3 million in the year-ago period and besting the average analyst estimate of $382.1 million.

The results were in line with what Illumina had pre-announced earlier this month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.